TG Therapeutics, Inc.
Pharmaceutical company · New York, United States · Nasdaq: TGTX
TG Therapeutics, Inc. is a pharmaceutical company headquartered in New York, United States. Its shares trade on Nasdaq under the ticker TGTX. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2012.
TG Therapeutics at a glance
What does TG Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $11.1 million sold (2012).
Frequently asked questions about TG Therapeutics
Where is TG Therapeutics headquartered?
TG Therapeutics, Inc. is headquartered in New York, United States.
What does TG Therapeutics do?
TG Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is TG Therapeutics a public company?
Yes. TG Therapeutics, Inc. trades on Nasdaq under the ticker TGTX.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.